Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis

INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive diffuse parenchymal lung disorder of unknown etiology. Mesenchymal stem cell (MSC)-based therapy is a novel approach with great therapeutic potential for the treatment of lung diseases. Despite demonstration of MSC grafting, the population...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stem Cell Res Ther
Hlavní autoři: Lan, Ying-Wei, Choo, Kong-Bung, Chen, Chuan-Mu, Hung, Tsai-Hsien, Chen, Young-Bin, Hsieh, Chung-Hsing, Kuo, Han-Pin, Chong, Kowit-Yu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4487587/
https://ncbi.nlm.nih.gov/pubmed/25986930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0081-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky